| CAT No: | Cl-FBS-03 |
| CAS No: | NA |
| Mol.F: | C21H24N4O3 |
| Mol.Wt.: | 380.5 |
| Chemical Name: | N-(4,5-Dimethyl-1-oxo-2H-furo[3,4-d]pyridazin-7-yl)-2- [methyl- [(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]amino]acetamide |
| Inventory Status: | Custom synthesis |
This impurity is related to Flibanserin Impurity B is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Flibanserin Impurity B is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:N-(4,5-Dimethyl-1-oxo-2H-furo[3,4-d]pyridazin-7-yl)-2- [methyl- [(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]amino]acetamideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Flibanserin Molecular Formula: C21H24N4O3
Molecular Weight: 380.5
Storage: Store in a cool, dry place.
| Product Name: | Flibanserin Impurity B |
| CAS No: | |
| Mol.F.: | C21H24N4O3 |
| Mol.Wt.: | 380.5 |
Cat. No: Cl-FBS-01
CAS No: 167933-07-5
Mol. F: C20H21F3N4O
Mol. Wt: 390.4
Inv. Status: Custom Synthesis
Cat. No: Cl-FBS-02
CAS No: 2308544-63-8
Mol. F: C20H21F3N4O2
Mol. Wt: 406.4
Inv. Status: Custom Synthesis
Cat. No: Cl-FBS-04
CAS No: 231632-18-1
Mol. F: C20H22N4O3
Mol. Wt: 366.4
Inv. Status: Custom Synthesis
Cat. No: Cl-FBS-05
CAS No: (6629-3-10)
Mol. F: C16H14N4O2
Mol. Wt: 294.3
Inv. Status: Custom Synthesis
Cat. No: CL-FBS-NO-02
CAS No: NA
Mol. F: C11H12F3N3O
Mol. Wt: 259.23
Inv. Status: Custom Synthesis
Cat. No: CL-FBS-NO-01
CAS No: NA
Mol. F: C20H20F3N5O2
Mol. Wt: 419.41
Inv. Status: Custom Synthesis
Cat. No: CL-FBS-NO-03
CAS No: NA
Mol. F: C19H19N5O4
Mol. Wt: 381.39
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: